DK1259523T3 - Pluraflaviner og derivater deraf, fremgangsmåde til fremstilling og anvendelse deraf - Google Patents

Pluraflaviner og derivater deraf, fremgangsmåde til fremstilling og anvendelse deraf

Info

Publication number
DK1259523T3
DK1259523T3 DK01915255T DK01915255T DK1259523T3 DK 1259523 T3 DK1259523 T3 DK 1259523T3 DK 01915255 T DK01915255 T DK 01915255T DK 01915255 T DK01915255 T DK 01915255T DK 1259523 T3 DK1259523 T3 DK 1259523T3
Authority
DK
Denmark
Prior art keywords
pluraflavins
derivatives
preparation
Prior art date
Application number
DK01915255T
Other languages
English (en)
Inventor
Laszlo Vertesy
Klaus Ehrlich
Martin Knauf
Joachim Wink
Francis P Barbone
Elaine A Powers
Elizabeth A Cashman
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1259523T3 publication Critical patent/DK1259523T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/58—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01915255T 2000-02-18 2001-02-15 Pluraflaviner og derivater deraf, fremgangsmåde til fremstilling og anvendelse deraf DK1259523T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103540A EP1125944A1 (de) 2000-02-18 2000-02-18 Pluraflavine und Derivate davon, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2001/001660 WO2001060832A2 (en) 2000-02-18 2001-02-15 Pluraflavins and derivatives thereof, process for their preparation and use thereof

Publications (1)

Publication Number Publication Date
DK1259523T3 true DK1259523T3 (da) 2004-03-22

Family

ID=8167898

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01915255T DK1259523T3 (da) 2000-02-18 2001-02-15 Pluraflaviner og derivater deraf, fremgangsmåde til fremstilling og anvendelse deraf

Country Status (31)

Country Link
US (1) US6500936B2 (da)
EP (2) EP1125944A1 (da)
JP (1) JP4801307B2 (da)
KR (1) KR100743380B1 (da)
CN (1) CN1162441C (da)
AR (1) AR027436A1 (da)
AT (1) ATE255120T1 (da)
AU (2) AU2001242404B2 (da)
BR (1) BR0108128A (da)
CA (1) CA2400237C (da)
CZ (1) CZ303810B6 (da)
DE (1) DE60101313T2 (da)
DK (1) DK1259523T3 (da)
EE (1) EE05137B1 (da)
ES (1) ES2207609T3 (da)
HK (1) HK1052709B (da)
HR (1) HRP20020672B1 (da)
HU (1) HU228332B1 (da)
IL (2) IL151216A0 (da)
ME (1) ME00179B (da)
MX (1) MXPA02006919A (da)
NO (1) NO323413B1 (da)
PL (1) PL204842B1 (da)
PT (1) PT1259523E (da)
RS (1) RS49991B (da)
RU (1) RU2255940C2 (da)
SI (1) SI1259523T1 (da)
SK (1) SK286691B6 (da)
TR (1) TR200302180T4 (da)
WO (1) WO2001060832A2 (da)
ZA (1) ZA200206795B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
CN101921300B (zh) * 2009-06-10 2014-04-02 上海来益生物药物研究开发中心有限责任公司 一种异黄酮苷类化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187292A (en) * 1977-03-31 1980-02-05 Takeda Chemical Industries, Ltd. Antibiotics produced from the microorganism nocardice
DE3782930T2 (de) * 1986-07-21 1993-04-29 Kyowa Hakko Kogyo Kk Neue mittel dc-92b und dc-92d, sowie deren verfahren zur herstellung.
AU623923B2 (en) * 1988-07-22 1992-05-28 Masco Corporation A small hand-held shower head for domestic sinks connected to a faucet
US5001058A (en) * 1988-09-19 1991-03-19 Bristol-Myers Company BU-3839T antibiotic
PT93070A (pt) * 1989-02-07 1990-08-31 Abbott Lab Processo de preparacao de altromicinas e de composicoes farmaceuticas que as contem
US5168100A (en) * 1990-03-16 1992-12-01 Sapporo Breweries Limited Hp530 compounds and process for preparing the same
MX2009014082A (es) * 2007-07-06 2010-03-01 Rite Hite Holding Corp Barreras de seguridad retráctiles y sus métodos de operación.

Also Published As

Publication number Publication date
MXPA02006919A (es) 2004-04-05
SK11802002A3 (sk) 2003-02-04
KR100743380B1 (ko) 2007-07-30
DE60101313T2 (de) 2004-09-30
ME00179B (me) 2011-02-10
JP4801307B2 (ja) 2011-10-26
HK1052709A1 (en) 2003-11-21
NO20023845D0 (no) 2002-08-14
WO2001060832A2 (en) 2001-08-23
NO20023845L (no) 2002-10-10
HRP20020672B1 (en) 2010-12-31
CZ20022826A3 (cs) 2002-11-13
AU2001242404B2 (en) 2005-04-14
ZA200206795B (en) 2003-11-19
HUP0204393A3 (en) 2007-10-29
RU2002124772A (ru) 2004-02-20
US20020028921A1 (en) 2002-03-07
CN1162441C (zh) 2004-08-18
PT1259523E (pt) 2004-04-30
ATE255120T1 (de) 2003-12-15
RU2255940C2 (ru) 2005-07-10
MEP28608A (en) 2010-10-10
HUP0204393A2 (hu) 2003-07-28
YU57602A (sh) 2005-11-28
SK286691B6 (sk) 2009-03-05
DE60101313D1 (de) 2004-01-08
CN1404484A (zh) 2003-03-19
WO2001060832A3 (en) 2002-01-31
HRP20020672A2 (en) 2004-12-31
EE200200438A (et) 2003-12-15
TR200302180T4 (tr) 2004-03-22
EP1259523B1 (en) 2003-11-26
AR027436A1 (es) 2003-03-26
IL151216A (en) 2009-12-24
EP1259523A2 (en) 2002-11-27
SI1259523T1 (en) 2004-04-30
EE05137B1 (et) 2009-02-16
JP2003523346A (ja) 2003-08-05
NO323413B1 (no) 2007-04-30
PL358297A1 (en) 2004-08-09
BR0108128A (pt) 2003-02-25
KR20020086539A (ko) 2002-11-18
ES2207609T3 (es) 2004-06-01
CA2400237A1 (en) 2001-08-23
HK1052709B (zh) 2005-02-04
RS49991B (sr) 2008-09-29
AU4240401A (en) 2001-08-27
CZ303810B6 (cs) 2013-05-15
PL204842B1 (pl) 2010-02-26
US6500936B2 (en) 2002-12-31
EP1125944A1 (de) 2001-08-22
IL151216A0 (en) 2003-04-10
CA2400237C (en) 2008-12-30
HU228332B1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
EE05387B1 (et) KinasoliiniÁderivaadid,ÁnendeÁvalmistamismeetodÁjaÁkasutamine
IS7188A (is) Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun
NO20032332D0 (no) Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO20035325D0 (no) Hudpermeabelt selektiv cyklooksygenase-2-inhibitorpreparat
DK1339292T3 (da) Sammensætning og fremgangsmåde
IS6661A (is) Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
IS6531A (is) Aðferðir til að búa til klaríþrómýsín og klaríþrómýsínmilliefni, í megindráttum oxímlaust klaríþrómýsín og lyfjablanda sem inniheldur það
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1334106T3 (da) Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
IS2331B (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20031272L (no) Fremgangsmåte og form for kald isopressing
NO20024105D0 (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
DK1406895T3 (da) Lactonformuleringer og fremgangsmåde til anvendelse deraf
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse